²é¿´ÍêÕû°æ±¾: [-- µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© --]

¿¼²©ÂÛ̳ -> µÚËľüÒ½´óѧ -> µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© [´òÓ¡±¾Ò³] µÇ¼ -> ×¢²á -> »Ø¸´Ö÷Ìâ -> ·¢±íÖ÷Ìâ

leagecn 2007-01-20 18:03

µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£©

µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© ,9I-3**W  
`@1e{ ?$  
  Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© M6Xzyt|  
  1¡¢Co-stimulators (or co-stimulating molecules) 6XZjZ*)W  
  2¡¢NK-kB PknKzrEG:>  
  3¡¢Immunoglobulin superfamily ^W@8KB  
  4¡¢antigen-presenting cell (APC) z^tzP~nI  
  5¡¢death domain %vZHHBylu  
  6¡¢CCR and CXCR Bnk<e  
  7¡¢Lectin (or mitogen) B-KMlHe  
  8¡¢Clusters of differentiation, CD) `'XN2-M8  
  9¡¢B7 family e&T-G L  
  10¡¢Cytotoxic T lymphocyte, CTL) z3L=K9)  
  11¡¢IL-15 and IL-15 receptor (IL-15R) |1A0YjOD  
  12¡¢MHC restriction 3`{ vx  
  13¡¢Affinity-chromatography Srmr`[i  
  14¡¢Cyctosprin A, CsA i g7|kl  
  15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) sk 8DW  
q&9]4j  
  ¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© K2n#;fY %  
  1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 - (((y)!  
  2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ *}#HBZe(9  
  3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌص㡣 +'93%/:  
gk?H@b*  
  Èý¡¢ÎÊ´ðÌ⣨25·Ö£© b5]<!~Fv:`  
  1¡¢Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ?,v& o>*  
  ѪҺ²¡Ñ§×¨Òµ£º -Q<OSa='  
  2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿


²é¿´ÍêÕû°æ±¾: [-- µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© --] [-- top --]


Powered by freekaobo v7.5 SP3 Code ©2003-2010 PHPWind
Gzip enabled

You can contact us